Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Healthcare Finance topic

No spam. Unsubscribe anytime.

Fort Worth health fund faces deficit as GLP‑1 use rises; council debates reimbursement versus restriction

Fort Worth City Council · June 3, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Staff warned the group health fund is projected to run a deficit and cited sharply rising use of GLP‑1 drugs; council members debated policy options including audits, partial reimbursement (one proposal: up to $200 per employee) and whether restricting coverage could interfere with doctor‑patient relationships.

City staff told the council the group health fund is projected to operate at a deficit for FY27 and that rising pharmacy costs—driven in part by increased use of GLP‑1 drugs—are a major pressure.

The presenter said the city’s health plan has seen a surge in GLP‑1 utilization and that "the number of subscribers or members that are using GLP ones, purely for weight loss increased almost 50%" since the prior presentation. Staff described a cost‑containment focus: rebuilding a contingency reserve, rightsizing claims utilization, and exploring plan and program design changes to sustain the fund over multiple years.

Staff provided a planning estimate that claims and third‑party administration costs for the fund could total between $89 million and $99 million (staff characterized that range as the cost for claims and TPA for the referenced period). Council members asked whether the wellness and coaching vendors are local; staff said most are large branded programs and that the city has authority to engage a claims audit with Blue Cross Blue Shield as a best practice. Staff estimated the audit could yield about $800,000 in savings, while the audit cost was discussed at roughly $850,000.

Council discussion centered on how to respond to GLP‑1 cost growth. One council member argued against an outright prohibition, saying it could "interfere[] with my relationship with my doctor" and proposed a reimbursement model for employees, suggesting a cap of $200 as a policy option. Staff said one modeled option assumed covering 50% of the cost; staff also reminded council that the city already funds participation in NOOM as part of its offerings.

No formal action or vote was taken; staff said they will include options for the council to consider in the budget process.

Next steps: staff will return with options—including potential audits, benefit design changes, and reimbursement models—for council consideration during the budget cycle.